Urteste SA

WAR:URT Poland Biotechnology
Market Cap
$18.06 Million
zł75.08 Million PLN
Market Cap Rank
#31634 Global
#266 in Poland
Share Price
zł49.20
Change (1 day)
-3.15%
52-Week Range
zł28.40 - zł90.60
All Time High
zł180.00
About

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.

Urteste SA (URT) - Total Assets

Latest total assets as of September 2025: zł40.74 Million PLN

Based on the latest financial reports, Urteste SA (URT) holds total assets worth zł40.74 Million PLN as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Urteste SA - Total Assets Trend (2019–2024)

This chart illustrates how Urteste SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Urteste SA - Asset Composition Analysis

Current Asset Composition (December 2024)

Urteste SA's total assets of zł40.74 Million consist of 60.5% current assets and 39.6% non-current assets.

Asset Category Amount (PLN) % of Total Assets
Cash & Equivalents zł0.00 4.9%
Accounts Receivable zł7.38 Million 24.9%
Inventory zł0.00 0.0%
Property, Plant & Equipment zł0.00 0.0%
Intangible Assets zł8.90 Million 30.1%
Goodwill zł0.00 0.0%

Asset Composition Trend (2019–2024)

This chart illustrates how Urteste SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Urteste SA's current assets represent 60.5% of total assets in 2024, an increase from 20.3% in 2019.
  • Cash Position: Cash and equivalents constituted 4.9% of total assets in 2024, down from 14.0% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 0.0% in 2019.
  • Asset Diversification: The largest asset category is intangible assets at 30.1% of total assets.

Urteste SA Competitors by Total Assets

Key competitors of Urteste SA based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

Urteste SA - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.06

Lower asset utilization - Urteste SA generates 0.06x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -60.65% - -12.26%

Negative ROA - Urteste SA is currently not profitable relative to its asset base.

Urteste SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.80 15.53 1.10
Quick Ratio 1.80 15.53 1.10
Cash Ratio 0.00 0.00 0.00
Working Capital zł9.04 Million zł 19.52 Million zł 59.94K

Urteste SA - Advanced Valuation Insights

This section examines the relationship between Urteste SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.53
Latest Market Cap to Assets Ratio 0.15
Asset Growth Rate (YoY) 0.1%
Total Assets zł29.62 Million
Market Capitalization $4.54 Million USD

Valuation Analysis

Below Book Valuation: The market values Urteste SA's assets below their book value (0.15 x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Urteste SA's assets grew by 0.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Urteste SA (2019–2024)

The table below shows the annual total assets of Urteste SA from 2019 to 2024.

Year Total Assets Change
2024-12-31 zł29.62 Million +0.07%
2023-12-31 zł29.60 Million +342.16%
2022-12-31 zł6.69 Million -32.66%
2021-12-31 zł9.94 Million +618.59%
2020-12-31 zł1.38 Million +11.62%
2019-12-31 zł1.24 Million --